Healthcare provider profile · identity verified

Michael J Sikora, MD

Family Practice · SPOKANE, WA · NPI 1881729531

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	388	110
Levothyroxine Sodium	Levothyroxine Sodium	260	68
Lisinopril	Lisinopril	240	71
Omeprazole	Omeprazole	208	70
Losartan Potassium	Losartan Potassium	168	49
Amlodipine Besylate	Amlodipine Besylate	152	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	151	28
Simvastatin	Simvastatin	114	35
Gabapentin	Gabapentin	111	32
Trazodone Hcl	Trazodone Hcl	106	34
Jardiance	Empagliflozin	102	32
Metformin Hcl Er	Metformin Hcl	95	28
Tamsulosin Hcl	Tamsulosin Hcl	95	35
Albuterol Sulfate Hfa	Albuterol Sulfate	79	42
Pantoprazole Sodium	Pantoprazole Sodium	78	26
Metoprolol Succinate	Metoprolol Succinate	77	22
Fluoxetine Hcl	Fluoxetine Hcl	74	24
Rosuvastatin Calcium	Rosuvastatin Calcium	73	26
Hydrochlorothiazide	Hydrochlorothiazide	68	23
Prednisone	Prednisone	65	42
Metformin Hcl	Metformin Hcl	64	25
Allopurinol	Allopurinol	63	20
Furosemide	Furosemide	63	22
Pregabalin	Pregabalin	63	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	19
Lorazepam	Lorazepam	59	12
Potassium Chloride	Potassium Chloride	55	20
Citalopram Hbr	Citalopram Hydrobromide	53	14
Wixela Inhub	Fluticasone Propion/Salmeterol	50	12
Spironolactone	Spironolactone	49	15
Alvesco	Ciclesonide	46	12
Hydroxyzine Pamoate	Hydroxyzine Pamoate	46	11
Alendronate Sodium	Alendronate Sodium	43	16
Ozempic	Semaglutide	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	14
Famotidine	Famotidine	39	13
Fluticasone Propionate	Fluticasone Propionate	39	18
Duloxetine Hcl	Duloxetine Hcl	37	15
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	37	12
Estradiol	Estradiol	36	12
Metoprolol Tartrate	Metoprolol Tartrate	36	12
Bupropion Xl	Bupropion Hcl	35	11
Buspirone Hcl	Buspirone Hcl	35	suppressed
Tramadol Hcl	Tramadol Hcl	34	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	32	suppressed
Chlorthalidone	Chlorthalidone	31	12
Donepezil Hcl	Donepezil Hcl	31	12
Memantine Hcl	Memantine Hcl	29	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	12
Escitalopram Oxalate	Escitalopram Oxalate	28	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Doxepin Hcl	Doxepin Hcl	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Digoxin	Digoxin	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	25	23
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Finasteride	Finasteride	24	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Amoxicillin	Amoxicillin	20	17
Atenolol	Atenolol	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Eliquis	Apixaban	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Risperidone	Risperidone	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Trospium Chloride Er	Trospium Chloride	19	suppressed
Carvedilol	Carvedilol	18	suppressed
Cephalexin	Cephalexin	18	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Meloxicam	Meloxicam	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	11
Azithromycin	Azithromycin	12	12
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nystatin	Nystatin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Humulin N	Insulin Nph Human Isophane	11	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	11	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	11	suppressed
Naratriptan Hcl	Naratriptan Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error